Rational design of cationic lipids for siRNA delivery
Sean C. Semple(Arbutus Biopharma (Canada)), Michael J. Hope(Acuitas Therapeutics (Canada)), June Qin(Alnylam Pharmaceuticals (United States)), Lloyd B. Jeffs(Arbutus Biopharma (Canada)), Barbara L. Mui(Arbutus Biopharma (Canada)), Ismail M. Hafez(University of British Columbia), Todd Borland(Alnylam Pharmaceuticals (United States)), Rene Alvarez(Alnylam Pharmaceuticals (United States)), Masuna Srinivasulu(University of British Columbia), Kieu Lam(Arbutus Biopharma (Canada)), Antonin de Fougerolles(Alnylam Pharmaceuticals (United States)), Erin Crosley(Arbutus Biopharma (Canada)), Derrick Stebbing(Arbutus Biopharma (Canada)), Michael J Weinstein(Alnylam Pharmaceuticals (United States)), J. Robert Dorkin(Alnylam Pharmaceuticals (United States)), Pieter R. Cullis(University of British Columbia), Muthusamy Jayaraman(Alnylam Pharmaceuticals (United States)), Ed Yaworski(Arbutus Biopharma (Canada)), Ammen P. Sandhu(Arbutus Biopharma (Canada)), Ying K. Tam(Arbutus Biopharma (Canada)), Connie K Cho(Arbutus Biopharma (Canada)), Verbena Kosovrasti(Alnylam Pharmaceuticals (United States)), Martin A. Maier(Alnylam Pharmaceuticals (United States)), Marco A. Ciufolini(FPInnovations), Sandra K. Klimuk(Arbutus Biopharma (Canada)), Mikameh Kazem(University of British Columbia), Akin Akinc(Alnylam Pharmaceuticals (United States)), Muthiah Manoharan(Alnylam Pharmaceuticals (United States)), Lubomir V. Nechev(Alnylam Pharmaceuticals (United States)), Merete L. Eisenhardt(Arbutus Biopharma (Canada)), Kallanthottathil G. Rajeev(Alnylam Pharmaceuticals (United States)), Jianxin Chen(Tsinghua University), Qingmin Chen(Shandong University of Political Science and Law), Ian MacLachlan(Unknown), William Cantley(Alnylam Pharmaceuticals (United States)), Soma De(Alnylam Pharmaceuticals (United States)), Kim F. Wong(University of British Columbia), Mark A. Tracy(Alnylam Pharmaceuticals (United States)), Dinah W.Y. Sah(Port Washington Public Library), Thomas D. Madden(Arbutus Biopharma (Canada)), Scott Barros(Alnylam Pharmaceuticals (United States))
Cited by 1,778
Related Papers
Liposomal drug delivery systems: From concept to clinical applications
|Advanced Drug Delivery Reviews|2012|4.7k
Drug Delivery Systems: Entering the Mainstream
|Science|2004|4.5k
Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential
|Biochimica et Biophysica Acta (BBA) - Biomembranes|1985|2.1k
Lipid polymorphism and the functional roles of lipids in biological membranes
|Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes|1979|1.8k
Vesicles of variable sizes produced by a rapid extrusion procedure
|Biochimica et Biophysica Acta (BBA) - Biomembranes|1986|1.7k